Didier A - Search Results

1

Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.

Tiberghien F, Kurome T, Takesako K, Didier A, Wenandy T, Loor F. Tiberghien F, et al. Among authors: didier a. J Med Chem. 2000 Jun 29;43(13):2547-56. doi: 10.1021/jm990955w. J Med Chem. 2000. PMID: 10891114

2

Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.

Loor F, Tiberghien F, Wenandy T, Didier A, Traber R. Loor F, et al. Among authors: didier a. J Med Chem. 2002 Oct 10;45(21):4598-612. doi: 10.1021/jm0109863. J Med Chem. 2002. PMID: 12361387

3

Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.

Loor F, Tiberghien F, Wenandy T, Didier A, Traber R. Loor F, et al. Among authors: didier a. J Med Chem. 2002 Oct 10;45(21):4613-28. doi: 10.1021/jm010987v. J Med Chem. 2002. PMID: 12361388

4

Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors.

Didier AD, Loor F. Didier AD, et al. Int J Cancer. 1995 Oct 9;63(2):263-7. doi: 10.1002/ijc.2910630220. Int J Cancer. 1995. PMID: 7591215

5

Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin A.

Didier A, Tiberghien F, Wenger R, Loor F. Didier A, et al. Anticancer Drugs. 1996 May;7(3):257-65. doi: 10.1097/00001813-199605000-00004. Anticancer Drugs. 1996. PMID: 8791998

6

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

Didier A, Loor F. Didier A, et al. Anticancer Drugs. 1996 Sep;7(7):745-51. doi: 10.1097/00001813-199609000-00005. Anticancer Drugs. 1996. PMID: 8949985

7

SDZ PSC 833 and SDZ 280-446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells.

Pourtier-Manzanedo A, Didier AD, Muller CD, Loor F. Pourtier-Manzanedo A, et al. Among authors: didier ad. Anticancer Drugs. 1992 Aug;3(4):419-25. doi: 10.1097/00001813-199208000-00017. Anticancer Drugs. 1992. PMID: 1421439

8

Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.

Pourtier-Manzanedo A, Didier A, Loor F. Pourtier-Manzanedo A, et al. Among authors: didier a. Oncol Res. 1992;4(11-12):473-80. Oncol Res. 1992. PMID: 1363723

9

Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers.

Didier A, Wenger J, Loor F. Didier A, et al. Anticancer Drugs. 1995 Oct;6(5):669-80. doi: 10.1097/00001813-199510000-00006. Anticancer Drugs. 1995. PMID: 8845477

10

The MultiScreen filtration system to measure chemoattractant-induced release of leukocyte granule enzymes by differentiated HL-60 cells or normal human monocytes.

Tiberghien F, Didier A, Bohbot A, Loor F. Tiberghien F, et al. Among authors: didier a. J Immunol Methods. 1999 Feb 1;223(1):63-75. doi: 10.1016/s0022-1759(98)00202-6. J Immunol Methods. 1999. PMID: 10037235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters